Pharming Group NV (PHAR) — Cash Flow Reinvestment Rate
Pharming Group NV (PHAR) has a Cash Flow Reinvestment Rate of 0.15x as of March 2026, reinvesting $238.86K (capex $238.86K ) from operating cash flow of $1.63 Million. Check Pharming Group NV earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharming Group NV Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Pharming Group NV across 7 annual periods. Explore how much of Pharming Group NV's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pharming Group NV (2017–2025)
Year-by-year capital reinvestment analysis for Pharming Group NV. For live market cap and broader valuation context, see how much is Pharming Group NV worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.72x | $85.97 Million | $50.07 Million | $751.09K | ▲ +428.3% |
| 2022 | 0.33x | $7.30 Million | $22.46 Million | $1.98 Million | ▼ -40.2% |
| 2021 | 0.54x | $20.59 Million | $37.84 Million | $16.72 Million | ▲ +191.8% |
| 2020 | 0.19x | $15.59 Million | $83.63 Million | $15.30 Million | ▼ -50.6% |
| 2019 | 0.38x | $27.95 Million | $74.15 Million | $25.45 Million | ▲ +155.5% |
| 2018 | 0.15x | $6.81 Million | $46.19 Million | $4.31 Million | ▼ -30.7% |
| 2017 | 0.21x | $9.76 Million | $45.84 Million | $7.25 Million | — |